Legal & General Group PLC Clear Point Neuro, Inc. Transaction History

Legal & General Group PLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$6.03 - $7.86 $838 - $1,092	-139 Reduced 5.79%	2,261 $15,000
Q4 2023 Feb 15, 2024	SELL	$4.46 - $7.07 $1,431 - $2,269	-321 Reduced 11.8%	2,400 $16,000
Q2 2023 Aug 14, 2023	BUY	$6.54 - $10.58 $17,795 - $28,788	2,721 New	2,721 $19,000
Q2 2022 Aug 22, 2022	SELL	$7.09 - $13.65 $14,116 - $27,177	-1,991 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$17.23 - $22.77 $34,304 - $45,335	1,991 New	1,991 $38,000

6.81M

84.3K

56.7K

Ticker CLPT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,488,300
Market Cap $400M
Description
ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain ...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.